THrombolysis for Acute Wake-up and Unclear-onset Strokes With Alteplase at 0.6 mg/kg Trial (THAWS)
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to clarify efficacy and safety of MRI-based intravenous
thrombolysis with alteplase for patients with acute wake-up ischemic stroke and those having
acute ischemic stroke with unknown time of symptom onset.
Phase:
Phase 3
Details
Lead Sponsor:
National Cerebral and Cardiovascular Center
Collaborators:
Charitable Trust Mihara Cerebrovascular Disorder Research Promotion Fund Japan Agency for Medical Research and Development